Automatic Optical Identification of the Spine Vertebrate Using Three-dimensional Optical Detection Based on a CT Test
Launched by DEEP HEALTH LTD. · May 30, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method to help doctors identify parts of the spine, such as the vertebrae and discs, using 3D images from CT scans. The goal is to improve how spinal surgeries are performed by providing clearer and more precise images of the spine. This can help ensure better outcomes for patients undergoing surgery.
To be eligible for this study, participants should be men or women aged 18 and older who have had a spinal CT scan and are planning to have spinal surgery. There are no specific health conditions that would exclude someone from participating. If you join the study, you can expect to contribute to important research that may enhance the safety and effectiveness of spinal surgery in the future. The trial is currently looking for participants, so if you or someone you know fits the criteria, it could be a great opportunity to help advance medical care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • men and women
- • 18 and above years old
- • Patients who have available spinal CT tests will be included in the study
- • Patients who are about to undergo spinal surgery
- Exclusion Criteria:
- • NA
About Deep Health Ltd.
Deep Health Ltd. is an innovative clinical trial sponsor dedicated to advancing healthcare through cutting-edge research and development. Focused on harnessing the power of technology and data analytics, the company specializes in conducting trials that explore novel therapeutic interventions and medical devices. Committed to patient-centered approaches, Deep Health Ltd. prioritizes ethical standards and regulatory compliance, ensuring the safety and efficacy of its studies. By collaborating with healthcare professionals and research institutions, the company aims to bring transformative solutions to the market, ultimately enhancing patient outcomes and improving public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jerusalem, , Israel
Patients applied
Trial Officials
Josh Schroeder, MD
Principal Investigator
Advisor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials